Back to ICD-10 library
ICD-10-CM · FY 2026 APRIL UPDATE

T44.5X

Poisoning by, adverse effect of and underdosing of predominantly beta-adrenoreceptor agonists

Diagnosis reference

Nonbillable category

This entry is a category or subcategory. Choose the appropriate billable descendant based on the clinical documentation.

Effective periodOctober 1, 2026–September 30, 2027
SourceCMS ICD-10-CM order file
ClassificationDiagnosis · clinical modification

Related entries

Up to 30 descendants in this category

CODEDESCRIPTIONTYPE
T44.5X1Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional)Category
T44.5X1APoisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), initial encounterBillable
T44.5X1DPoisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), subsequent encounterBillable
T44.5X1SPoisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), sequelaBillable
T44.5X2Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harmCategory
T44.5X2APoisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, initial encounterBillable
T44.5X2DPoisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, subsequent encounterBillable
T44.5X2SPoisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, sequelaBillable
T44.5X3Poisoning by predominantly beta-adrenoreceptor agonists, assaultCategory
T44.5X3APoisoning by predominantly beta-adrenoreceptor agonists, assault, initial encounterBillable
T44.5X3DPoisoning by predominantly beta-adrenoreceptor agonists, assault, subsequent encounterBillable
T44.5X3SPoisoning by predominantly beta-adrenoreceptor agonists, assault, sequelaBillable
T44.5X4Poisoning by predominantly beta-adrenoreceptor agonists, undeterminedCategory
T44.5X4APoisoning by predominantly beta-adrenoreceptor agonists, undetermined, initial encounterBillable
T44.5X4DPoisoning by predominantly beta-adrenoreceptor agonists, undetermined, subsequent encounterBillable
T44.5X4SPoisoning by predominantly beta-adrenoreceptor agonists, undetermined, sequelaBillable
T44.5X5Adverse effect of predominantly beta-adrenoreceptor agonistsCategory
T44.5X5AAdverse effect of predominantly beta-adrenoreceptor agonists, initial encounterBillable
T44.5X5DAdverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounterBillable
T44.5X5SAdverse effect of predominantly beta-adrenoreceptor agonists, sequelaBillable
T44.5X6Underdosing of predominantly beta-adrenoreceptor agonistsCategory
T44.5X6AUnderdosing of predominantly beta-adrenoreceptor agonists, initial encounterBillable
T44.5X6DUnderdosing of predominantly beta-adrenoreceptor agonists, subsequent encounterBillable
T44.5X6SUnderdosing of predominantly beta-adrenoreceptor agonists, sequelaBillable

Use the complete reference

This reference does not reproduce the full tabular hierarchy, inclusion notes, Excludes1/2 notes, sequencing instructions, or seventh-character rules. Review the official tables and coding guidelines.

Open official CMS files

ICD-10-CM codes describe diagnoses. They do not have an independent Medicare PFS reimbursement amount, and billability alone does not establish coverage.